Skip to main content
A

Aier Eye Hospital Group Co.,Ltd. — Investor Relations & Filings

Ticker · 300015 Shenzhen Stock Exchange Human health and social work activities
Open in API
Filings indexed 2,700 across all filing types
Latest filing 2026-04-23 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300015

About Aier Eye Hospital Group Co.,Ltd.

https://www.aierchina.com

Aier Eye Hospital Group Co., Ltd. is a global ophthalmic medical institution specializing in comprehensive eye care services. The group operates an extensive network of specialized hospitals providing clinical diagnosis, surgical intervention, and therapeutic treatments. Core medical services encompass refractive surgery, cataract treatment, glaucoma management, vitreoretinal disease care, and pediatric ophthalmology, with a significant focus on myopia prevention and control. The organization integrates clinical practice with academic research and professional education, maintaining a multi-tiered medical service system designed to improve accessibility to specialized eye care. Its service model emphasizes the application of advanced ophthalmic technologies and standardized clinical protocols across its international network of medical facilities.

Recent filings

Filing Released Lang Actions
2025年年度董事会审计委员会履职报告
Governance Information Classification · 1% confidence The document is titled “2025年年度董事会审计委员会履职报告” (“2025 Annual Board Audit Committee Performance Report”) and contains details of the audit committee’s membership, meetings, review of financial reports, supervision of funds, evaluation of external auditors and internal controls, and future work plan. It is not an earnings release, proxy, dividend notice, or full annual/interim financial report, nor is it a brief notice of report publication. Instead, it is a governance‐related committee performance report detailing internal governance practices and board committee activities. This fits the Governance Information category (CGR).
2026-04-23 Chinese
关于修订H股发行上市后适用的《公司章程》 及相关内部治理制度的公告
Regulatory Filings
2026-04-23 Chinese
董事会薪酬与考核委员会关于回购注销2021年限制性股票激励计划已获授但尚未解除限售的限制性股票的核查意见
Transaction in Own Shares Classification · 1% confidence The document is a public announcement by the Board’s Compensation and Evaluation Committee regarding the company’s repurchase and cancellation of restricted shares under its 2021 stock incentive plan. It details the repurchase quantity, price, and regulatory compliance, fitting the category of a transaction in own shares (share buyback/cancellation). This aligns with our POS category (Report of the company buying back or selling its own shares).
2026-04-23 Chinese
关于2025年年度利润分配预案的公告
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement of the company’s 2025 annual profit distribution plan, detailing the cash dividend per share (1 RMB per 10 shares), total dividend amount, record date considerations, and board resolutions. This is a Notice of Dividend Amount, not a full report or financial statement, and matches the “Notice of Dividend Amount” category.
2026-04-23 Chinese
华泰联合证券有限责任公司关于爱尔眼科2025年度募集资金存放与使用情况专项核查报告
Audit Report / Information Classification · 1% confidence The document is a detailed “专项核查报告” on the deposit and use of proceeds for the 2025 fiscal year, prepared by the sponsor (华泰联合证券) with an attached assurance opinion from 中审众环会计师事务所. It is not the company’s Annual Report (10-K) or an earnings release but a standalone verification/audit of fundraising proceeds usage, matching the definition of an Audit Report/Information. Thus, the correct classification is AR.
2026-04-23 Chinese
2025年年度报告
Regulatory Filings
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.